NCT06166797View on ClinicalTrials.gov

Elucidating Growth Hormone Dynamics at Stages of Progressive Nonalcoholic Fatty Liver Disease

Not yet recruitingOBSERVATIONAL

Enrollment

60

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions

Nonalcoholic Fatty Liver Disease

All Listed Sponsors

lead

Massachusetts General Hospital

OTHER

NCT06166797 - Elucidating Growth Hormone Dynamics at Stages of Progressive Nonalcoholic Fatty Liver Disease | Biotech Hunter | Biotech Hunter